Peptides Derived of Kunitz-Type Serine Protease Inhibitor as Potential Vaccine Against Experimental Schistosomiasis

Schistosomiasis is a significant public health problem in sub-Saharan Africa, China, Southeast Asia, and regions of South and Central America affecting about 189 million people. Kunitz-type serine protease inhibitors have been identified as important players in the interaction of other flatworm para...

Full description

Autores:
Tipo de recurso:
Fecha de publicación:
2019
Institución:
Universidad del Rosario
Repositorio:
Repositorio EdocUR - U. Rosario
Idioma:
eng
OAI Identifier:
oai:repository.urosario.edu.co:10336/24088
Acceso en línea:
https://doi.org/10.3389/fimmu.2019.02498
https://repository.urosario.edu.co/handle/10336/24088
Palabra clave:
CD1 antigen
Epitope
Ion channel
Serine proteinase inhibitor
Vaccine
Adult
Animal experiment
Animal model
Animal tissue
Article
Bioinformatics
Biomphalaria glabrata
Cercaria
Controlled study
Drug efficacy
Echinococcus multilocularis
Enzyme linked immunosorbent assay
Fasciola hepatica
Female
Fibrinolysis
Gene expression
Inflammation
Molecular genetics
Mouse
Nonhuman
Peptide synthesis
Polymerase chain reaction
Reversed phase high performance liquid chromatography
Schistosoma granulosus
Schistosoma haematobium
Schistosoma japonicum
Schistosoma mansoni
Schistosomiasis
Schistosomulum
Stereomicroscopy
Upregulation
Vaccination
ADAD vaccination system
Helminth vaccines
Immunomodulator AA0029
Kunitz-type proteins
Schistosoma mansoni
Synthetic peptide
Rights
License
Abierto (Texto Completo)
Description
Summary:Schistosomiasis is a significant public health problem in sub-Saharan Africa, China, Southeast Asia, and regions of South and Central America affecting about 189 million people. Kunitz-type serine protease inhibitors have been identified as important players in the interaction of other flatworm parasites with their mammalian hosts. They are involved in host blood coagulation, fibrinolysis, inflammation, and ion channel blocking, all of them critical biological processes, which make them interesting targets to develop a vaccine. Here, we evaluate the protective efficacy of chemically synthesized T- and B-cell peptide epitopes derived from a kunitz protein from Schistosoma mansoni. Putative kunitz-type protease inhibitor proteins were identified in the S. mansoni genome, and their expression was analyzed by RNA-seq. Gene expression analyses showed that the kunitz protein Smp_147730 (Syn. Smp_311670) was dramatically and significantly up-regulated in schistosomula and adult worms when compared to the invading cercariae. T- and B-cell epitopes were predicted using bioinformatics tools, chemically synthesized, and formulated in the Adjuvant Adaptation (ADAD) vaccination system. BALB/c mice were vaccinated and challenged with S. mansoni cercariae. Kunitz peptides were highly protective in vaccinated BALB/c mice showing significant reductions in recovery of adult females (89–91%) and in the numbers of eggs trapped in the livers (77–81%) and guts (57–77%) of mice. Moreover, liver lesions were significantly reduced in vaccinated mice (64–65%) compared to infected control mice. The vaccination regime was well-tolerated with both peptides. We propose the use of these peptides, alone or in combination, as reliable candidates for vaccination against schistosomiasis. © Copyright © 2019 Hernández-Goenaga, López-Abán, Protasio, Vicente Santiago, del Olmo, Vanegas, Fernández-Soto, Patarroyo and Muro.